NanoViricides
NNVC
#10484
Rank
A$50.57 M
Marketcap
A$1.98
Share price
-1.41%
Change (1 day)
-16.05%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of March 2026 : A$14.47 Million

According to NanoViricides's latest financial reports the company's total assets are A$14.47 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2026)

Total assets by year

Year Total assets Change
2025-06-30A$13.41 M-30.18%
2024-06-30A$19.21 M-24.24%
2023-06-30A$25.35 M-25.55%
2022-06-30A$34.06 M-15.61%
2021-06-30A$40.36 M16.49%
2020-06-30A$34.64 M80.95%
2019-06-30A$19.14 M-23.57%
2018-06-30A$25.05 M-28.77%
2017-06-30A$35.17 M-28.49%
2016-06-30A$49.18 M-14.36%
2015-06-30A$57.42 M23.47%
2014-06-30A$46.51 M158.8%
2013-06-30A$17.97 M17.78%
2012-06-30A$15.26 M52.03%
2011-06-30A$10.03 M-5.45%
2010-06-30A$10.61 M186.17%
2009-06-30A$3.7 M141.65%
2008-06-30A$1.53 M-3.73%
2007-06-30A$1.59 M-56.79%
2006-06-30A$3.69 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
A$79.73 B 550,619.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$182.32 B 1,259,171.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$122.51 B 846,127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$117.96 B 814,649.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.47 B 10,108.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.65 B 4,450.86%๐Ÿ‡บ๐Ÿ‡ธ USA